Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • Symptoms to Watch For
  • Who Is at Risk?
  • Diagnosis and Testing

What You Need to Know About Glucocorticoid-Induced Myopathy

What You Need to Know About Glucocorticoid-Induced Myopathy

The Big Picture

Glucocorticoid-induced myopathy is a muscle condition caused by certain medications. Understanding its symptoms and risk factors is essential for effective management.
Contents
  • Symptoms to Watch For
  • Who Is at Risk?
  • Diagnosis and Testing

Symptoms to Watch For

Glucocorticoid myopathy typically presents with gradual weakness in muscles close to the body's core, such as the thighs and shoulders. This weakness can make it difficult to perform everyday tasks like climbing stairs or lifting objects. Unlike other muscle disorders, this condition does not cause muscle pain or tenderness.

Who Is at Risk?

The condition is more likely in individuals taking high doses of glucocorticoids, especially for prolonged periods. Older adults and those with physical inactivity, cancer, or respiratory conditions are at higher risk. The type of glucocorticoid preparation used can also influence risk levels.
A muscle condition caused by prolonged use of glucocorticoids, characterized by weakness in muscles close to the body's core.

Diagnosis and Testing

Diagnosing glucocorticoid-induced myopathy relies on patient history and the exclusion of other causes. Muscle enzyme levels are usually normal, and electromyography can show a specific pattern of muscle activity. Improvement in muscle strength after reducing glucocorticoid dosage supports the diagnosis.

FAQs

What are the symptoms of glucocorticoid myopathy?

It causes gradual muscle weakness without pain.

Who is most at risk?

Older adults and those on high-dose glucocorticoids.

How is it diagnosed?

Through patient history and ruling out other causes.

Can it occur with all glucocorticoids?

It is more common with systemic glucocorticoids.

Wrapping Up

Understanding symptoms and risk factors is crucial for managing glucocorticoid-induced myopathy.
Talk to Doctronic to learn more about managing this condition effectively.
Additional References
  1. Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 2013; 17:913.
  2. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985; 76:234.
  3. Afifi AK, Bergman RA, Harvey JC. Steroid myopathy. Clinical, histologic and cytologic observations. Johns Hopkins Med J 1968; 123:158.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.